Japan
Two new diabetes drugs approved
May 28, 2015Sales and Marketing Japan, Takeda, diabetes in China, lilly
Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …
Eisai seeks new ALS drug approval
May 28, 2015Sales and Marketing Eisai, Japan, als, mecobalamin
Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …
AbbVie hep C drug gets priority review in Japan
April 16, 2015Sales and Marketing AbbVie, EC, EU, Europe, Exviera, FDA, Japan, Viekira Pak, Viekirax, hepatitis C, ombitasvir/paritaprevir/ritonavir
AbbVie’s combination hepatitis C treatment looks set to be approved in yet another country after being granted priority review in …
Bayer and Regeneron eye drug gains another indication
March 26, 2015Sales and Marketing Bayer, Eylea, FDA, Japan, Lucentis, MRI, Regeneron, aflibercept
Bayer and Regeneron’s Eylea has added to a growing list of indications with its new approval to treat a type …
Eisai launches Lenvima in US
March 2, 2015Sales and Marketing FDA, Japan, Lenvima, US, dtc, thyroid
Japanese firm Eisai has launched its new thyroid cancer offering Lenvima in the US, making it the first country in …
Takeda trial hits late-stage buffers
February 17, 2015Research and Development, Sales and Marketing AMG 706, Japan, NSCLC, Takeda, lung cancer, motesanib
Takeda is to scrap an advanced trial of an investigational drug after it failed to show any benefit in survival …
UK lags behind in healthcare outcomes index
November 26, 2014Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes
Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …
GE and Takeda make liver pact
November 13, 2014Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash
GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …
Novartis faces data fraud charges in Japan
July 3, 2014Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan
Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …
Toshiba creates disease diagnosis tool
May 13, 2014Medical Communications, Research and Development, Sales and Marketing Disease, Japan, breath analyser, toshiba
Japan’s multinational electronics firm Toshiba has developed a breath-analysing prototype system that it says can be used to diagnose diseases. …
Police raid Novartis Tokyo office
February 20, 2014Medical Communications, Sales and Marketing Diovan, Japan, Novartis, tokyo
Authorities in Japan have raided the premises of Novartis’ Tokyo operation as part of an ongoing investigation into the promotion …
Novartis faces Japan probe
January 10, 2014Sales and Marketing Diovan, Japan, Novartis
Novartis is under pressure in Japan where authorities are looking at the way the Swiss firm promoted its blood pressure …
Eisai signs tropical disease deal
November 12, 2013Research and Development, Sales and Marketing Disease, Eisai, Japan, broad, ntd, tropical
Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …
Novartis ‘sorry’ for Diovan data
September 27, 2013Sales and Marketing Japan, Novartis, diovan data
Novartis has apologised to patients in Japan over the alleged manipulation of data in five trials of its blockbuster blood …
Latest content
